Excel Diagnostics & Nuclear Oncology Center has the highest level of experience performing radioisotope therapy for neuroendocrine tumors in the United States. At the office in Houston, Texas, Ebrahim Delpassand, MD, and the team have been using this therapy since 2010 to help hundreds of patients with this rare type of cancer. Call Excel Diagnostics & Nuclear Oncology Center to schedule radioisotope therapy or book online today.
Radioisotope therapy is a molecular-targeted therapy that treats neuroendocrine tumors (NET). The team at Excel Diagnostics & Nuclear Oncology Center uses peptide receptor radionuclide therapy (PRRT) to identify and attack cancer cells without harming healthy tissue nearby.
During radioisotope PRRT therapy, the team delivers high doses of radiation into tumors to slow their growth or destroy them with a high level of precision. Treatment can also reduce the side effects of the cancer and prevent permanent tissue damage.
Neuroendocrine tumors are cancers that begin in the neuroendocrine cells, specialized cells that are similar to hormone-producing cells and nerve cells. These types of cancers are rare and can develop anywhere in your body.
Some of the common areas where neuroendocrine tumors develop include the:
The tumor may grow slowly or quickly, and you may not have any symptoms in the initial stages of the cancer. As the cancer progresses, you might feel a lump under your skin or have pain from the tumor. If you have tumors that produce excess hormones, you might experience frequent urination, dizziness, or diarrhea depending on the location of the tumor.
The team at Excel Diagnostics & Nuclear Oncology Center offers diagnostic imaging tests including positron emission tomography (PET) scans and computed tomography (CT) scans to identify neuroendocrine tumors and may recommend radioisotope therapy to treat them.
During radioisotope therapy, the Excel Diagnostics & Nuclear Oncology Center delivers somatostatin analogues (peptides) that detect tumor cells and attach to their receptors to create a radiopharmaceutical.
This allows the team to target neuroendocrine tumors and deliver therapeutic doses of radiation directly into them. This type of targeted cancer therapy effectively destroys abnormal cells and tumors without causing major side effects or damaging nearby tissue.
The team also provides on-site imaging tests including PET/CT scans that you may need throughout your therapy to ensure treatment is working.
To find out if radioisotope therapy can work for you, call Excel Diagnostics & Nuclear Oncology Center today to schedule a consultation or book an appointment online.